What is the purpose of antiplatelet medications after a myocardial infarction (MI)?

Prepare for the OPSA Essentials Test. Study with flashcards, multiple choice questions, hints, and explanations for every question. Get exam-ready now!

Multiple Choice

What is the purpose of antiplatelet medications after a myocardial infarction (MI)?

Explanation:
After a myocardial infarction, preventing another clot is essential. Antiplatelet medications block platelet aggregation, which reduces the risk of recurrent thrombosis at the site of plaque rupture and improves survival. Aspirin inhibits thromboxane A2 production in platelets, lowering their activation, while other agents like P2Y12 inhibitors prevent ADP-mediated platelet aggregation. Together, they form a cornerstone of post-MI therapy. They do not raise platelet activity, they do not directly lower LDL cholesterol, and they do not increase heart rate.

After a myocardial infarction, preventing another clot is essential. Antiplatelet medications block platelet aggregation, which reduces the risk of recurrent thrombosis at the site of plaque rupture and improves survival. Aspirin inhibits thromboxane A2 production in platelets, lowering their activation, while other agents like P2Y12 inhibitors prevent ADP-mediated platelet aggregation. Together, they form a cornerstone of post-MI therapy. They do not raise platelet activity, they do not directly lower LDL cholesterol, and they do not increase heart rate.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy